BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27282921)

  • 1. Improvement of core-fucosylated glycoproteome coverage via alternating HCD and ETD fragmentation.
    Ma C; Qu J; Li X; Zhao X; Li L; Xiao C; Edmunds G; Gashash E; Song J; Wang PG
    J Proteomics; 2016 Sep; 146():90-8. PubMed ID: 27282921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A precise approach in large scale core-fucosylated glycoprotein identification with low- and high-normalized collision energy.
    Ma C; Zhang Q; Qu J; Zhao X; Li X; Liu Y; Wang PG
    J Proteomics; 2015 Jan; 114():61-70. PubMed ID: 25220145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategy integrating stepped fragmentation and glycan diagnostic ion-based spectrum refinement for the identification of core fucosylated glycoproteome using mass spectrometry.
    Cao Q; Zhao X; Zhao Q; Lv X; Ma C; Li X; Zhao Y; Peng B; Ying W; Qian X
    Anal Chem; 2014 Jul; 86(14):6804-11. PubMed ID: 24914453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GlycoMaster DB: software to assist the automated identification of N-linked glycopeptides by tandem mass spectrometry.
    He L; Xin L; Shan B; Lajoie GA; Ma B
    J Proteome Res; 2014 Sep; 13(9):3881-95. PubMed ID: 25113421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systems analysis of singly and multiply O-glycosylated peptides in the human serum glycoproteome via EThcD and HCD mass spectrometry.
    Zhang Y; Xie X; Zhao X; Tian F; Lv J; Ying W; Qian X
    J Proteomics; 2018 Jan; 170():14-27. PubMed ID: 28970103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A strategy for precise and large scale identification of core fucosylated glycoproteins.
    Jia W; Lu Z; Fu Y; Wang HP; Wang LH; Chi H; Yuan ZF; Zheng ZB; Song LN; Han HH; Liang YM; Wang JL; Cai Y; Zhang YK; Deng YL; Ying WT; He SM; Qian XH
    Mol Cell Proteomics; 2009 May; 8(5):913-23. PubMed ID: 19139490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Core-Fucosylated Glycoproteome in Human Plasma.
    Cao Q; Zhao Q; Qian X; Ying W
    Methods Mol Biol; 2017; 1619():127-137. PubMed ID: 28674882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated Strategy for Large-Scale Investigation on Protein Core Fucosylation Stoichiometry Based on Glycan-Simplification and Paired-Peaks-Extraction.
    Zhao X; Yu Z; Huang Y; Liu C; Wang M; Li X; Qian X; Ying W
    Anal Chem; 2020 Feb; 92(4):2896-2901. PubMed ID: 31986883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of CID, HCD, and ETD with FT MS/MS for degradomic-peptidomic analysis: comparison of peptide identification methods.
    Shen Y; Tolić N; Xie F; Zhao R; Purvine SO; Schepmoes AA; Moore RJ; Anderson GA; Smith RD
    J Proteome Res; 2011 Sep; 10(9):3929-43. PubMed ID: 21678914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of Core-Fucosylated Glycopeptides Based on the Y1+Fuc/Y1 Ratio in Low-Energy HCD Spectra.
    Chen Z; Shen J; Dong W; Li P; Xin M; Liu D; Jia L; Zhu B; Li W; Sun S
    Anal Chem; 2022 Dec; 94(50):17349-17353. PubMed ID: 36484784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidation of N-glycosites within human plasma glycoproteins for cancer biomarker discovery.
    Drake P; Schilling B; Gibson B; Fisher S
    Methods Mol Biol; 2013; 951():307-22. PubMed ID: 23296540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of core fucosylation via sequential enzymatic treatments of intact glycopeptides and mass spectrometry analysis.
    Cao L; Lih TM; Hu Y; Schnaubelt M; Chen SY; Zhou Y; Guo C; Dong M; Yang W; Eguez RV; Chen L; Clark DJ; Sodhi A; Li QK; Zhang H
    Nat Commun; 2022 Jul; 13(1):3910. PubMed ID: 35798744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragmentation and site-specific quantification of core fucosylated glycoprotein by multiple reaction monitoring-mass spectrometry.
    Zhao Y; Jia W; Wang J; Ying W; Zhang Y; Qian X
    Anal Chem; 2011 Nov; 83(22):8802-9. PubMed ID: 21970473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoproteomic analysis of the secretome of human endothelial cells.
    Yin X; Bern M; Xing Q; Ho J; Viner R; Mayr M
    Mol Cell Proteomics; 2013 Apr; 12(4):956-78. PubMed ID: 23345538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational classification of core and outer fucosylation of N-glycoproteins in human plasma using collision-induced dissociation in mass spectrometry.
    Jeong HK; Hwang H; Kang YM; Lee HK; Park GW; Lee JY; Kim DG; Lee JW; Lee SY; An HJ; Kim JY; Yoo JS
    Rapid Commun Mass Spectrom; 2020 Dec; 34(23):e8917. PubMed ID: 32754952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher energy collision dissociation (HCD) product ion-triggered electron transfer dissociation (ETD) mass spectrometry for the analysis of N-linked glycoproteins.
    Singh C; Zampronio CG; Creese AJ; Cooper HJ
    J Proteome Res; 2012 Sep; 11(9):4517-25. PubMed ID: 22800195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parallel data acquisition of in-source fragmented glycopeptides to sequence the glycosylation sites of proteins.
    Zhao J; Song E; Zhu R; Mechref Y
    Electrophoresis; 2016 Jun; 37(11):1420-30. PubMed ID: 26957414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.
    Chen R; Jiang X; Sun D; Han G; Wang F; Ye M; Wang L; Zou H
    J Proteome Res; 2009 Feb; 8(2):651-61. PubMed ID: 19159218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Core-Fucosylated Glycoproteins by Single-Step Truncation of N-Glycans.
    Min Y; Zhao X; Ying W
    Curr Protoc; 2024 Jan; 4(1):e982. PubMed ID: 38270535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-Specific
    Li J; Jia L; Hao Z; Xu Y; Shen J; Ma C; Wu J; Zhao T; Zhi Y; Li P; Li J; Zhu B; Sun S
    J Proteome Res; 2020 Aug; 19(8):3191-3200. PubMed ID: 32425043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.